Correlation Study Between Heart Rate Variability and Anxiety in Anorexia Nervosa
VARIASTRESS
2 other identifiers
interventional
13
1 country
1
Brief Summary
The heart rate variability (HRV) is a measure of the autonomic nervous system (ANS). In the model of anorexia nervosa, ANS is disturbed with mostly a predominance of activation of the parasympathetic nervous system and a decrease of the sympathetic system. Various explanations of this these dysfunctions are proposed in literature, mainly malnutrition, physical hyperactivity, anxiety, that are known characteristics of anorexia nervosa. The primary aim of this study is to evaluate correlation between ANS dysfunction and anxiety in anorexia nervosa. Other objectives of this study are firstly to evaluate correlation between ANS dysfunction and others parameters (weight, body mass index, depression, physical activity, purgative ou restrictive type, duration of disease, smoking) in anorexia nervosa and secondly to see if HRV is a predictive parameter of the evolution of anorexia nervosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2016
CompletedFirst Posted
Study publicly available on registry
December 28, 2016
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2018
CompletedDecember 12, 2019
December 1, 2019
1.5 years
December 22, 2016
December 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Statistical correlation between autonomic dysfunction (measured by HRV) and anxiety (measured by questionnaire)
The composite measure consists of the following :- Time and spectral-domain measures of HRV measured by nocturn registration with heart rate monitor and polar RS800CX Time domain - NN (normal-to-normal R-R interval), HRV index (total number of all NN/ the height of the histogram of all NN), SDNN (standard deviation of the NN), RMSSD (the root mean square of differences of successive NN), NN50 (Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording) and pNN50 (NN50/total number of all NN), SDANN (Standard deviation of the average of NN intervals in all 5-minute segments of a long recording), SDNNIDX (Mean of the standard deviation in all 5-minute segments of a long recording) Frequency domain - VLF Power (very low frequency; \<0.04 Hz), LF Power (low frequency; 0.04\~0.15 Hz), HF Power (high frequency; 0.15\~0.4 Hz), LF/HF ratio value \- State-Trait Anxiety Inventory: version Y (STAI- form Y) - Morning blood cortisol level and serum prealbumin lev
at day 0
Secondary Outcomes (4)
Statistical correlation between autonomic dysfunction (measured by HRV) and measures of Beck Depression inventory
at day 0
Statistical correlation between autonomic dysfunction (measured by HRV) and measures of Beck Depression inventory
at 6 months
Statistical correlation between autonomic dysfunction (measured by HRV) and measures of International physical activity questionnaire
at 6 months
Statistical correlation between autonomic dysfunction (measured by HRV) and measures of International physical activity questionnaire
at day 0
Study Arms (1)
Heart rate monitor
EXPERIMENTALThe intervention consist in monitoring the heart rate variability during one night by using a heart rate monitor and a Polar RS800CX
Interventions
The intervention consist in monitoring the heart rate variability during one night by using a heart rate monitor and a Polar RS800CX
Eligibility Criteria
You may qualify if:
- Women
- Aged from 18 to 65 years
- Criteria of anorexia nervosa (DSM V)
- Body mass index (BMI) \< 18 kg/m2
- Written consent to participate in the study
- Patient affiliated to a social security system
You may not qualify if:
- Pacemaker or other implantable electronic device
- Current comorbidity psychiatric disorder according to Axis I of DSM IV : severe depression (BDI \> 8/13), substance use disorder .
- Psychotropic drugs or ongoing steroid therapy ;
- Pregnancy or breast-feeding ;
- History or known cardiovascular disorder, including hypertension ( \> 140/90 mmHg ) , heart failure, arrhythmia and conduction disorder .
- Major protected by a legal protection
- Minors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvain ICETA, MD
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2016
First Posted
December 28, 2016
Study Start
March 1, 2017
Primary Completion
September 12, 2018
Study Completion
September 12, 2018
Last Updated
December 12, 2019
Record last verified: 2019-12